Form 8-K - Current report:
SEC Accession No. 0001493152-24-028329
Filing Date
2024-07-18
Accepted
2024-07-18 16:05:17
Documents
17
Period of Report
2024-07-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39941
2 ex10-1.htm EX-10.1 23974
3 ex10-1_001.jpg GRAPHIC 26294
4 ex10-1_002.jpg GRAPHIC 10813
5 ex10-1_003.jpg GRAPHIC 8963
  Complete submission text file 0001493152-24-028329.txt   299709

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE mrzm-20240712.xsd EX-101.SCH 3015
7 XBRL LABEL FILE mrzm-20240712_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE mrzm-20240712_pre.xml EX-101.PRE 22359
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3341
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME, INC. (Filer) CIK: 0001413754 (see all company filings)

EIN.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53223 | Film No.: 241124813
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)